The violations resolved in this settlement consist of multiple failures by DuPont to report information about substantial risk of injury to human health or the environment by perfluorooctanoic acid, or PFOA. PFOA is used during the manufacture of fluoropolymers, which are used in common household products such as nonstick cookware. DuPont will pay $10.25 million […]
The List of Pest Control Product Formulants and Contaminants of Health or Environmental Concern has been published in the Canada Gazette, Part II. This is a necessary step toward bringing into force the new Pest Control Products Act, which was given Royal Assent in December 2002. Establishing the List is necessary to meet the objectives […]
After an extensive, multi-year scientific and technical review, EPA has removed methyl ethyl ketone (MEK) from the Clean Air Act list of toxic air pollutants. Declassifying MEK will not compromise public health and may even pose a public health benefit as companies substitute MEK for more toxic or environmentally damaging chemicals. Although removed from the […]
The European Commission welcomes the Council’s political agreement on a comprehensive new system aimed at ensuring greater safety in the manufacture and use of chemical substances. The new system, REACH, will establish an integrated system for the registration, evaluation, authorisation and restriction of chemicals. REACH will ensure that the gaps in existing information on the […]
1. Part I of the Non-domestic Substances List (see footnote 1) is amended by deleting the following: 5719-73-3 52320-66-8 126990-35-0 13587-19-4 70983-77-6 145417-44-3 15217-42-2 74499-71-1 216439-38-2 17865-32-6 82168-31-8 38783-61-8 84434-11-7 – 2. Part II of the List is amended by deleting the following: 14424-6 Rosin, maleated, polymer with an alkylphenol, formaldehyde, pentaerythritol and polymerized rosin […]
The Food and Drug Administration today is alerting health care professionals and patients about early results of new studies for Paxil (paroxetine) suggesting that the drug increases the risk for birth defects, particularly heart defects, when women take it during the first three months of pregnancy. Paxil is approved for the treatment of depression and […]
The U.S. Consumer Product Safety Commission (CPSC) today announced an agreement with the Mexican government aimed at further improving consumer safety and making both the United States and Mexican marketplaces among the safest in the world. This agreement is also part of the “Security and Prosperity Partnership” between the U.S., Mexico, and Canada. CPSC Chairman […]
As part of the Food and Drug Administration’s continued commitment to improve communication about risks posed by prescription medications, its Center for Drug Evaluation and Research (CDER) is holding a public meeting today to evaluate current practices and to explore new tools and strategic partnerships to enhance future efforts. “In the past year we have […]
Acting Assistant Secretary of Labor for Occupational Safety and Health Jonathan L. Snare today signed a two-year renewal of the Society for Chemical Hazard Communication (SCHC) Alliance that will continue to focus on providing information and education on hazard communication and chemical safety. Through the OSHA and SCHC Alliance renewal, the organizations will continue to […]
Chemicals Listed Effective December 2, 2005 as Known to the State of California to Cause Reproductive Toxicity: butyl benzyl phthalate (BBP) (CAS No. 85 68-7) di-n-butyl phthalate (DBP) (CAS No. 84-74-2) di-n-hexyl phthalate (DnHP) (CAS No. 84-75-3) Source